Showing 6631-6640 of 8473 results for "".
- Dr. Zein Obagi to Introduce New ZO Skin Health Treatment Systems At The 2014 AAD Annual Meetinghttps://practicaldermatology.com/news/20140306-dr_zein_obagi_to_introduce_new_zo_skin_health_treatment_systems_at_the_2014_aad_annual_meeting/2459323/
- Aquavit Pharmaceuticals Appoints David J. Goldberg as Chief Medical Officerhttps://practicaldermatology.com/news/20140305-aquavit_pharmaceuticals_appoints_david_j_goldberg_as_chief_medical_officer/2459324/Aquavit Pharmaceuticals, Inc., appointed David J. Goldberg, MD, JD as its Chief Medical Officer. Dr. Goldberg is recognized nationally and internationally for his innovative work with skin lasers, cosmetic dermatology and facial rejuvenation techniques. Prior to joining Aquavit,
- Allergies to Pre-Moistened Wipes on the Risehttps://practicaldermatology.com/news/20140303-allergies_to_pre-moistened_wipes_on_the_rise/2459326/A preservative in pre-moistened hand wipes may be linked to a rise of allergic reactions, according to dermatologist Matthew Zirwas, MD at the Ohio State University Wexner Center. He says manufacturers are increasing use of the preservative as they reduce their dependence on formaldehyde and para
- Mirvaso Approved by the European Commissionhttps://practicaldermatology.com/news/20140226-mirvaso_approved_by_the_european_commission/2459330/The European Commission has granted marketing authorization in Europe for Galderma's Mirvaso (brimonidine) 3 mg/g gel. Mirvaso, an alpha-2 adrenergic receptor agonist that acts rapidly and can last for up to 12 hours, is indicated for the symptomatic tr
- Nestle Skin Health Forming with Acquisition of Galdermahttps://practicaldermatology.com/news/20140214-nestl_skin_health_forming_with_acquisition_of_galderma/2459341/
- DEKA Medical Receives FDA Clearance for the Synchro REPLA:Yhttps://practicaldermatology.com/news/20140213-deka_medical_receives_fda_clearance_for_the_synchro_replay/2459343/The FDA cleared DEKA Medical, Inc.'s Synchro REPLA:Y, an aesthetic workstation dedicated, but not limited, to high speed stable long-term, or permanent hair reduction, treatment of PFB, treatment of benign pigmented lesions, treatment of wrinkles and
- Topix Pharmaceuticals Introduces Replenix Restorative Nighttime Bio-Therapyhttps://practicaldermatology.com/news/20140213-topix_pharmaceuticals_introduces_replenix_restorative_nighttime_bio-therapy/2459344/Topix Pharmaceuticals, Inc., launched its Replenix Restorative Nighttime Bio-Therapy cream, a moisture-boosting, rich night cream formulated to attract, hold, and distribute moisture through a system of ceramides, humectants, and em
- Acella Pharmaceuticals Announces Approval and Launch of Loutrex Topical Creamhttps://practicaldermatology.com/news/20140131-acella_pharmaceuticals_announces_approval_and_launch_of_loutrex_topical_cream/2459352/
- Study to Convert Adult Human Cells to Hair-Follicle-Generating Stem Cells has Implications for Hair Regenerationhttps://practicaldermatology.com/news/20140129-study_to_convert_adult_human_cells_to_hair-follicle-generating_stem_cells_has_implications_for_hair_regeneration/2459356/
- Curt Cole Wins "Best Presentation of the Day" and Lifetime Achievement Awards at Winter Clinical Dermatology Conferencehttps://practicaldermatology.com/news/20140128-curt_cole_wins_best_presentation_of_the_day_and_lifetime_achievement_awards_at_winter_clinical_dermatology_conference/2459357/"Beyond Broad Spectrum: Critical Concepts in a Post-Monograph World " - a podium presentation by photobiologist and industry veteran Curtis Cole, Ph.D, - was voted "Best Presentation of the Day," Tuesday, January 21 at the Winter Clinical Dermatology Conference. Given the broad scope of topics